Telix’s Illuccix PSMA-PET Imaging Agent Approved in France
April 29, 2025
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent Telix Pharmaceuticals Limited announces that its prostate cancer PET imaging agent, Illuccix